Comparative effectiveness of pharmacogenomic-guided versus unguided antidepressant treatment in major depressive disorder: new insights from subgroup and cumulative meta-analyses.

Although the test for subgroup differences did not reach statistical significance for remission at 8 weeks, these findings imply that genetic and pharmacological factors might interact differently among various ethnic groups, potentially affecting the effectiveness of PGx-guided interventions.

also in 111,027 other papers